Global Growth Companies With Insider Ownership Up To 27%
As global markets navigate through inflation concerns and rising interest rates, growth stocks have shown resilience, particularly in the technology sector. In this environment, companies with high insider ownership can be appealing as they often indicate confidence from those most familiar with the business.
Top 10 Growth Companies With High Insider Ownership Globally
| Name | Insider Ownership | Earnings Growth |
| Shanghai Biren Technology (SEHK:6082) | 10.4% | 119.7% |
| Pharma Mar (BME:PHM) | 12.1% | 39.8% |
| Meitu (SEHK:1357) | 23% | 26.9% |
| Meiko Electronics (TSE:6787) | 19.2% | 33.8% |
| KebNi (OM:KEBNI B) | 16.3% | 103.8% |
| Gpixel Changchun Microelectronics (SEHK:3277) | 18.2% | 31.9% |
| Gold Road International (OB:GOLDR) | 35.9% | 89.8% |
| CD Projekt Red (WSE:CDR) | 35.2% | 53.9% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 39.2% |
| Beijing Luzhu Biotechnology (SEHK:2480) | 39.7% | 84.3% |
Let's take a closer look at a couple of our picks from the screened companies.
ALTEOGEN (KOSDAQ:A196170)
Simply Wall St Growth Rating: ★★★★★★
Overview: ALTEOGEN Inc., a biotechnology company, specializes in developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩17.58 trillion.
Operations: The company's revenue segment is primarily derived from biotechnology, totaling ₩254.01 million.
Insider Ownership: 25.3%
Alteogen Inc. is poised for substantial growth, with earnings forecasted to rise by 35.84% annually, outpacing the KR market's 28.2%. Recent agreements with Novartis AG and another global pharmaceutical company could bring in up to US$3.59 billion if all milestones are achieved, enhancing revenue potential significantly. The stock trades slightly below its estimated fair value and boasts a high return on equity forecast of 40.4%, underscoring its strong growth trajectory without recent insider trading activity noted.
- Click to explore a detailed breakdown of our findings in ALTEOGEN's earnings growth report.
- Our expertly prepared valuation report ALTEOGEN implies its share price may be too high.
Wens Foodstuff Group (SZSE:300498)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Wens Foodstuff Group Co., Ltd. operates in the agricultural and animal husbandry sectors both in China and internationally, with a market cap of CN¥99.21 billion.
Operations: Wens Foodstuff Group's revenue primarily stems from its agricultural and animal husbandry operations across domestic and international markets.
Insider Ownership: 27.8%
Wens Foodstuff Group's recent earnings report showed a decline in sales and a significant net loss, contrasting with last year's profits. Despite this setback, the company is trading well below its estimated fair value and is expected to become profitable within three years, with an impressive annual earnings growth forecast of 88.78%. However, its revenue growth lags behind the broader Chinese market. No substantial insider trading activity has been reported recently.
- Click here and access our complete growth analysis report to understand the dynamics of Wens Foodstuff Group.
- The analysis detailed in our Wens Foodstuff Group valuation report hints at an deflated share price compared to its estimated value.
C Sun Mfg (TWSE:2467)
Simply Wall St Growth Rating: ★★★★★☆
Overview: C Sun Mfg Ltd., along with its subsidiaries, offers a range of processing equipment in Taiwan, China, and internationally, with a market cap of NT$83.38 billion.
Operations: The company's revenue segments include NT$4.93 billion from Csun Industrial, NT$1.34 billion from C Sun Manufacturing LTD, and NT$2.49 billion from Suzhou Top Creation Machines Co Ltd.
Insider Ownership: 10.8%
C Sun Mfg's earnings report highlights robust growth, with second-quarter sales reaching TWD 2.78 billion, up from TWD 1.51 billion a year ago, and net income rising to TWD 640.18 million from TWD 207.25 million. The company is expected to maintain strong revenue and earnings growth rates above market averages at over 30% and nearly 42%, respectively, despite high volatility in its share price and substantial non-cash earnings impacting quality assessments.
- Click here to discover the nuances of C Sun Mfg with our detailed analytical future growth report.
- Our valuation report unveils the possibility C Sun Mfg's shares may be trading at a discount.
Turning Ideas Into Actions
- Delve into our full catalog of 719 Fast Growing Global Companies With High Insider Ownership here.
- Ready To Venture Into Other Investment Styles? Outshine the giants: these 18 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com